[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"wound-care\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:wound-care":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,48,85,122,141,167,188],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":4,"maxAge":16,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100642258","registry-of-outcomes-of-dezawa-musecells-100642258",false,"NCT07645989","Registry of Outcomes of Dezawa MuseCells®","Inclusion Criteria:\n\n1. Received Dezawa MuseCells® as Part of Routine Clinical Care\n2. Patients ( and\u002For authorized representative) capable of providing informed consent and participating in long-term follow-up.\n3. Willingness to Complete Online Survey Assessments\n4. Participants must have reliable access to email or a mobile device and be willing to complete digital surveys at scheduled intervals over a 5-year period.\n5. Diagnosis of a Condition for Which Dezawa MuseCells® Were Administered Includes, but is not limited to, neurologic, musculoskeletal, cardiovascular, immunologic, and systemic degenerative conditions.\n6. Ability to Communicate in the Registry's Supported Language\n7. Participants must be able to read and respond to registry surveys in the designated study language.\n8. Enrollment Within 12 Months of MuseCell® Administration\n\nExclusion Criteria:\n\n1. Not Receive Dezawa MuseCells®-Individuals who have not been treated with Dezawa MuseCells® or received a counterfeit\u002Fnon-licensed product cannot be included.\n2. Unable or Unwilling to Provide Informed Consent Includes individuals with cognitive impairment who lack a legally authorized representative willing to consent on their behalf.\n3. Inability to Participate in Long-Term Digital Follow-Up\n4. Concurrent Participation in an Interventional Clinical Trial Affecting Outcomes\n5. History of Malignancy Diagnosed Within the Past 12 Months\n6. Excludes patients with active or recently treated cancer unless their treating physician determines participation poses no additional safety concerns.\n7. Any Condition That, in the Investigator's Judgment, Would Compromise Data Quality\n8. Use of Non-Licensed or Counterfeit \"Muse-like\" Cells Ensures that registry data reflect outcomes of authentic Dezawa MuseCells® produced under licensed methods.\n9. Pregnant or Actively Breastfeeding at Time of Enrollment","ALL","89 Years",{"count":18,"type":19},5000,"ESTIMATED","5 Years","OBSERVATIONAL","The goal of this observational study is to learn about the long-term effects of Dezawa MuseCells to treat various diseases.\n\nThe Primary Goal: What is the short-term and long- term outcomes of Dezawa Musecells? Participants treated with Dezawa MuseCells as part of their regular medical care and will answer online survey questions about symptoms and clinical outcomes for 5 years.",[24,25,26,27,28],"Osteoarthritis (OA)","Longevity","Wound Care","Pain","Orthopaedic",[30,31,32,33,34],"Muse Cells","stem cells","pain","wound","inflammation","RECRUITING","2026-06-11",{"date":38,"type":39},"2026-06-12","ACTUAL",{"date":41,"type":19},"2026-07-01",{"date":43,"type":19},"2031-12-31",{"name":45,"class":46},"MuseCell Innovations Pte LTD","INDUSTRY",2,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":15,"minAge":54,"maxAge":4,"enrollmentInfo":55,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":57,"conditions":58,"keywords":62,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":84},"100638268","ai-based-wound-monitoring-automated-wound-progression-assessment-via-marker-free-image-sequence-100638268","NCT07619430","AI-Based Wound Monitoring: Automated Wound Progression Assessment Via Marker-Free Image Sequence","Inclusion Criteria:\n\n* (1) Presence of a hard-to-heal wound that has remained unhealed for more than one month. (2)The wound can be photographed according to the standardized imaging protocol. (3)The participant was aged 18 years or older and provided informed consent personally or via a legally authorized representative, with a signed informed consent form.\n\nExclusion Criteria:\n\n* Wounds whose margins could not be fully included within the imaging field.","18 Years",{"count":56,"type":19},1000,"This study aims to develop a low-cost, marker-free intelligent wound assessment system that can analyze wound photos taken with a standard smartphone. By comparing wound images over time, the system will generate a quantifiable Wound Progression Index (WPI) to provide objective feedback on whether a wound is improving, stable, or worsening. The long-term goal is to support early detection of wound deterioration and improve wound care in both clinical and home settings.",[59,60,26,61],"Hard-to-heal Wounds","AI (Artificial Intelligence)","Pressure Injuries",[63,64,65,66,67,68,69,70,71,72],"chronic wounds","wound assessment","medical AI","semantic segmentation","longitudinal image registration","marker-free","wound progression index","home-based care","telemedicine","clinical validation","NOT_YET_RECRUITING","2026-05-27",{"date":76,"type":39},"2026-06-02",{"date":78,"type":19},"2026-06-08",{"date":80,"type":19},"2027-12-31",{"name":82,"class":83},"National Taiwan University Hospital","OTHER",1,{"id":86,"slug":87,"hasResults":11,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":4,"eligibilityCriteria":91,"healthyVolunteers":92,"sex":15,"minAge":54,"maxAge":4,"enrollmentInfo":93,"targetDuration":4,"studyType":95,"phases":96,"briefSummary":98,"conditions":99,"keywords":102,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":84},"100636175","using-woundpilot-to-support-wound-care-decisions-in-patients-with-chronic-wounds-100636175","NCT07562269","Using WoundPilot to Support Wound Care Decisions in Patients With Chronic Wounds","Evaluation of the Effect of WoundPilot on the Accuracy and Consistency of Clinical Decision-Making in Chronic Wound Care: A Randomized Parallel Vignette Study Among Primary Care Nurses","Inclusion Criteria:\n\n* Primary care nurses involved in wound care decision-making\n* Nurses working in home care or nursing home settings\n* Nurses who assess and\u002For adapt wound management in clinical practice\n* Nurses with a qualification corresponding to European Qualification Framework (EQF) level 5 or 6\n* Willing and able to provide informed consent\n\nExclusion Criteria:\n\n* Nurses not involved in wound care decision-making\n* Nurses not working in a primary care setting\n* Inability to understand the study procedures or complete the assessment tasks\n* Refusal or inability to provide informed consent",true,{"count":94,"type":19},40,"INTERVENTIONAL",[97],"NA","This study evaluates whether a digital decision support tool, called WoundPilot, can help primary care nurses make more accurate and consistent decisions when caring for patients with chronic wounds.\n\nIn daily practice, treatment decisions for chronic wounds can vary between clinicians, even when they assess the same patient. This variation may lead to delays in appropriate care, inconsistent treatment choices, or unnecessary referrals. WoundPilot was developed to guide clinicians through a structured wound assessment and link this assessment to clear treatment recommendations.\n\nIn this study, primary care nurses will assess a series of clinical cases either with or without the support of WoundPilot. Their decisions will be compared with an expert reference standard to determine whether the use of WoundPilot improves the accuracy of decisions and reduces differences between nurses.\n\nThe results of this study will help determine whether WoundPilot can support more consistent and evidence-based wound care in clinical practice.",[100,26,101],"Wound Complication","Wound and Injuries",[103,104,105,106,107,108,109,110,111,112],"chronic wound","wound care","clinical decision-making","decision support system","WoundPilot","Primary Care Nursing","Wound Assessment","decision-making","clinical reasoning","hard-to-heal wound","2026-04-24",{"date":115,"type":39},"2026-05-01",{"date":117,"type":19},"2026-06-01",{"date":119,"type":19},"2026-09",{"name":121,"class":83},"University Ghent",{"id":123,"slug":124,"hasResults":11,"nctId":125,"briefTitle":126,"officialTitle":127,"acronym":4,"eligibilityCriteria":128,"healthyVolunteers":11,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":129,"targetDuration":130,"studyType":21,"phases":4,"briefSummary":131,"conditions":132,"keywords":4,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":133,"lastUpdatePostDateStruct":134,"startDateStruct":136,"completionDateStruct":137,"leadSponsor":139,"locationsCount":4},"100635515","plasma-therapy-for-diverse-wounds-100635515","NCT07553689","Plasma Therapy for Diverse Wounds","A Prospective, Multicenter, Real-World Observational Study of a Plasma Device for Adjunctive Therapy in Acute Wounds, Chronic Wounds, Post-Grafting Wounds, and Sutured Wounds","Inclusion Criteria:\n\n* Presence of any of the following wound types: acute wounds (burns, trauma, surgical incisions, skin avulsions), chronic wounds (diabetic foot ulcers, pressure injuries, venous ulcers, radiation ulcers, burn residual wounds), post-grafting wounds (autograft or allograft, including donor and recipient sites), or sutured wounds (postoperative incisions, flap surgery, tension-reducing sutures).\n* Age ≥ 12 years (for minors under 18 years, informed consent must be provided by a parent or legal guardian).\n* Stable vital signs and able to tolerate wound treatment.\n* Willing to participate and able to provide signed informed consent.\n\nExclusion Criteria:\n\n* Active malignant tumor involving the wound area.\n* Severe systemic infection or sepsis.\n* Severe immunodeficiency or long-term use of high-dose corticosteroids.\n* Intolerance to plasma therapy or refusal to participate.\n* Pregnancy or breastfeeding.",{"count":56,"type":19},"6 Months","This study is a prospective, multicenter, real-world observational study. It aims to evaluate whether adding plasma device therapy to standard wound care is effective and safe for treating different types of wounds, including acute wounds (such as burns and surgical incisions), chronic wounds (such as diabetic foot ulcers and pressure injuries), post-grafting wounds, and sutured wounds.\n\nA total of 500 patients receiving standard wound care plus plasma therapy will be enrolled from multiple hospitals across China. Their outcomes will be compared with 500 matched patients who received standard wound care alone. The main outcomes include wound healing rate at 4 weeks, time to complete wound closure, pain relief, scar formation, and any side effects. Patients will be followed for up to 6 months.",[26],"2026-04-23",{"date":135,"type":39},"2026-04-28",{"date":115,"type":19},{"date":138,"type":19},"2029-12-31",{"name":140,"class":83},"First Affiliated Hospital, Sun Yat-Sen University",{"id":142,"slug":143,"hasResults":11,"nctId":144,"briefTitle":145,"officialTitle":145,"acronym":146,"eligibilityCriteria":147,"healthyVolunteers":11,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":148,"targetDuration":4,"studyType":95,"phases":150,"briefSummary":151,"conditions":152,"keywords":154,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":158,"lastUpdatePostDateStruct":159,"startDateStruct":161,"completionDateStruct":163,"leadSponsor":165,"locationsCount":47},"100627376","the-pain-reduction-using-immersive-virtual-reality-during-wound-care-evaluation-study-at-maimonides-prism---pilot-study-100627376","NCT07447830","The Pain Reduction Using Immersive Virtual Reality During Wound Care Evaluation Study at Maimonides (PRISM) - Pilot Study","PRISM","Inclusion Criteria:\n\n* Resident of LTC for ≥2 weeks\n* Receiving regular wound care for pressure ulcers\n* Able to tolerate iVR headset use\n* (If cognitively apt) able to understand English or French\n\nExclusion Criteria:\n\n* Blindness, severe cataracts, or glaucoma\n* Allergies to synthetic plastics or headset materials\n* Head or ear wounds preventing headset placement\n* Peripheral neuropathy\n* Dangerous or aggressive behaviors in the past 30 days",{"count":149,"type":19},25,[97],"This study will test whether immersive virtual reality (iVR) can reduce pain and discomfort during wound care for residents living in long-term care (LTC). Pressure ulcers are common and painful among older adults, and dressing changes often cause additional distress.\n\nUp to 20 residents at the Donald Berman Maimonides Geriatric Centre will use virtual reality headsets during routine wound care. The headsets display calm, low-stimulus scenes (e.g., puppies in a meadow) designed to distract and comfort participants.\n\nEach participant will take part for six weeks in three phases:\n\n* Two weeks of usual wound care (baseline)\n* Two weeks using virtual reality during wound care (intervention)\n* Two weeks of usual care again (washout)\n\nPain will be assessed using validated tools, and the research team will also observe agitation, mood, and other behavioral indicators. Nursing staff will provide feedback on feasibility and acceptability of iVR use in LTC settings.",[26,27,153],"Neuropsychiatric Symptoms",[155,32,104,156,157],"immersive virtual reality","depression","aggitation","2026-03-03",{"date":160,"type":39},"2026-03-05",{"date":162,"type":39},"2025-11-01",{"date":164,"type":19},"2027-04-15",{"name":166,"class":83},"McGill University",{"id":168,"slug":169,"hasResults":11,"nctId":170,"briefTitle":171,"officialTitle":171,"acronym":4,"eligibilityCriteria":172,"healthyVolunteers":11,"sex":15,"minAge":173,"maxAge":4,"enrollmentInfo":174,"targetDuration":4,"studyType":95,"phases":176,"briefSummary":177,"conditions":178,"keywords":4,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":179,"lastUpdatePostDateStruct":180,"startDateStruct":182,"completionDateStruct":184,"leadSponsor":186,"locationsCount":4},"100619812","a-pac-post-market-clinical-study-to-demonstrate-color-change-in-the-woundcue-kit-when-an-elevated-inhibitory-bacterial-andor-fungal-load-is-present-in-a-wound-100619812","NCT07349485","A PAC Post-Market Clinical Study to Demonstrate Color Change in the WoundCue™ Kit When an Elevated Inhibitory Bacterial and\u002For Fungal Load is Present in a Wound","Inclusion Criteria:\n\n* Arm 1:\n\nSubjects will be considered qualified for enrollment if they meet the following criteria:\n\nSubjects and\u002For Legally Authorized Representative (LAR) must voluntarily provide written Informed Consent, consisting of reading, signing, and dating the Informed Consent document after the Principal Investigator, sub-Principal Investigator, or other designated Study Staff member has explained the Study procedures, risks, and contact information.\n\nAble and willing to comply with all Study requirements.\n\nSubject can be Male or Female but must be over 21 years of age.\n\nSubject is currently under the care of a Primary Care Physician.\n\nSubject has an anticipated survival of greater than two months.\n\nSubject has a moderate to high exudate wound that has visible fluorescence when using MolecuLightDX™ or MolecuLight i:X™ imaging.\n\nArm 2:\n\nSubjects will be considered qualified for enrollment if they meet the following criteria:\n\nSubjects and\u002For Legally Authorized Representative (LAR) must voluntarily provide written Informed Consent, consisting of reading, signing, and dating the Informed Consent document after the Principal Investigator, sub-Investigator, or other designated Study Staff member has explained the Study procedures, risks, and contact information.\n\nAble and willing to comply with all Study requirements.\n\nSubject can be Male or Female but must be over 21 years of age.\n\nSubject is currently under the care of a Primary Care Physician.\n\nSubject has an anticipated survival of greater than two months.\n\nSubject has a moderate to high exudate wound.\n\n\\*For this Study, moderate exudate is defined as a wound that may require a dressing change 2-3 times a week based on provider judgement. Heavy exudate is defined as a wound that may require a dressing change 4 or more times a week based on provider judgement.\n\nExclusion Criteria:\n\n* Subject's target treatment area has a surface area larger than 5 cm2.\n\nKnown sensitivity or allergy to the Study Device or adhesives\u002Fadhesive-related products.\n\nCurrent use of topical ointments, including over-the-counter products and prescription drugs, on or near the intended treatment area.\n\nCurrent use or recent history (within the past 14 days) of antibiotics, either oral, systemic, or topical.\n\nUndergoing therapy with another investigational agent that may affect the WoundCueTM Kit's performance within thirty (30) days of Study Visit 1 or planned participation overlapping with this Study.\n\nWomen who are pregnant, breastfeeding, or intend to become pregnant during the course of the Study.\n\nMedical condition that, in the opinion of the Principal Investigator, would preclude safe Subject participation in the Study.\n\nAdults who, in the judgment of the Investigator, lack the capacity to provide informed consent for themselves","21 Years",{"count":175,"type":19},50,[97],"The purpose of this research is to test if the investigational ParaNano WoundCue Kit can detect elevated inhibitory bacterial and\u002For fungal loads.",[26],"2026-01-27",{"date":181,"type":39},"2026-01-29",{"date":183,"type":19},"2026-01-21",{"date":185,"type":19},"2027-11-20",{"name":187,"class":46},"ParaNano, Inc.",{"id":189,"slug":190,"hasResults":11,"nctId":191,"briefTitle":192,"officialTitle":192,"acronym":4,"eligibilityCriteria":193,"healthyVolunteers":11,"sex":15,"minAge":54,"maxAge":4,"enrollmentInfo":194,"targetDuration":4,"studyType":95,"phases":196,"briefSummary":197,"conditions":198,"keywords":202,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":208,"lastUpdatePostDateStruct":209,"startDateStruct":211,"completionDateStruct":213,"leadSponsor":215,"locationsCount":4},"100589995","the-effect-of-wound-care-education-using-the-jigsaw-iv-learning-technique-on-nursing-students-knowledge-collaborative-learning-and-academic-motivation-100589995","NCT06961656","The Effect of Wound Care Education Using the Jigsaw IV Learning Technique on Nursing Students' Knowledge, Collaborative Learning, and Academic Motivation","Inclusion Criteria:\n\n* Not having taken a wound care education before\n* Willing to participate in the study voluntarily\n\nExclusion Criteria:\n\n* Being a nurse who graduated from secondary school and working in the clinic,\n* Having previously established an associate degree program related to health,\n* Not participating in theoretical lessons, demonstrations and group work, - The student wants to withdraw from the research at any stage,\n* Not filling out the data collection forms or filling them incompletely.",{"count":195,"type":19},100,[97],"This study aims to investigate the effects of wound care education given with the jigsaw IV learning technique on the knowledge, collaborative learning and motivation levels of nursing students. Second-year nursing students will be divided into two groups with simple randomization. The intervention group will be given a wound care training program with the jigsaw IV technique. The control group will be given wound care training with traditional education. Pre-test data will be collected before the training and post-test data will be collected after the training.",[199,200,201,26],"Nursing Students","Nursing Education","Jigsaw Technique",[203,204,205,206,207],"Jigsaw IV","Nursing students","Wound care","Collaboration","Motivation","2025-05-06",{"date":210,"type":39},"2025-05-08",{"date":212,"type":19},"2025-04-28",{"date":214,"type":19},"2025-05-01",{"name":216,"class":83},"Agri Ibrahim Cecen University"]